hundred dollar bills with pills

Have you ever heard of a house of cards? We’re not referring to the TV series. We mean a structure that will eventually collapse when it can no longer sustain itself. We fear that high drug prices will shortly cause the collapse of our entire health care system. That’s because hospitals, nursing homes, patients and insurance companies will no longer be able to afford the incredible costs of crucial medicines. If a drug for dementia were developed, it would break the bank.

Volume: The Old Business Model

Not very long ago the pharmaceutical industry made money based on how many pills it sold. The big money makers were brands like Lipitor, Nexium, Prilosec, Prozac, Valium, Xanax, Zantac and Zoloft. Many became household names.

The business model for drug companies was to first choose a health condition such as nervousness, insomnia, depression, heartburn or high cholesterol that affects millions of people. Then they developed a medication to help control that problem. If doctors would keep prescribing the drug for a really long time to millions of patients, the dollars would flow.

The marketing plan was to get as many people as possible taking these frequently prescribed medicines for as long as possible. Millions of individuals stayed on such drugs for years or even decades.

If stopping an anti-anxiety agent, antidepressant or heartburn drug suddenly led to uncomfortable symptoms, many people would choose to stay on the medicine indefinitely. Drug companies didn’t do a lot of research on withdrawal complaints and rarely offered providers clear guidelines on how to help patients taper off such medications. Why would they? The more people taking their pills the better!

The Edge of the Cliff:

Needless to say, big brand name drug makers worried about losing patent protection on their best sellers. That’s because once such drugs went off patent, generic companies jumped in to make copies that could be sold for a fraction of the cost.

Here are just a few examples based on data from The generic prices are with coupons from GoodRx.

A One Month Supply of:

Valium = $175-$200  Generic diazepam = $6-$11
Nexium = $275-$290 Generic esomeprazole = $18-$47
Prozac = $450-$550  Generic fluoxetine = $3-$15

It’s hardly any wonder that most people opt for generics. That’s especially true since insurance companies often refuse to pay for pricey brands. Not surprisingly, sales of branded drugs plummet once a generic version becomes available.

Why Are High Drug Prices Ravaging Healthcare?

To keep its shareholders happy, the pharmaceutical industry has had to come up with a new model. Instead of seeking common conditions, drug companies began searching for niche markets and charging extremely high prices.

Treatments for relatively rare diseases are known as orphan drugs and get special treatment from the FDA. When Congress passed the orphan drug legislation in 1983, it didn’t envision that pharmaceutical companies would make much money on these medications. In fact, they were referred to as:

“significant drugs of limited commercial value”

High Drug Prices for Orphans:

Now, however, the prices of many orphan drugs are stratospheric. Actimmune, used to treat a rare immunodeficiency disease, can cost up to $55,000 a month.

Treatments for Gaucher disease, a genetic condition that can become fatal if untreated, can run to $300,000 or more annually.

Spinraza, to treat spinal muscular atrophy, costs approximately $750,000 for the initial year of treatment.

A drug for Duchenne muscular dystrophy, Exondys 51, has an annual price tag of $300,000 after discounts, though some experts project anywhere from $750,000 to $1.5 million (New York Times, June 22, 2017). 

Making Billions from Orphan Drugs:

Nowadays, instead of “limited commercial value,” orphan drugs have become bonanzas. Some of them, like Humira, EnbrelRemicade and Revlimid, are among the top-selling drugs by dollar value. We are talking billions of dollars annually for each drug.

Cancer medications may also earn orphan drug designations. And that can mean that they earn big bucks as well. Some of the newer cancer medicines, such as Keytruda or Opdivo, can cost $100,000 or more annually.

The hottest new immunotherapy for cancer involves personalized CAR-T treatment. You can learn more about chimeric antigen receptor T cell therapy at this link.

Is CAR-T for Cancer the Latest Immunotherapy Breakthrough

And the use of CAR-T for B cell lymphoma patients at this link:

CAR-T Immunotherapy Produces Stunning Results vs. B Cell Lymphoma

The total cost including hospitalization can exceed $500,000.

High Drug Prices = the New Pharmaceutical Model:

Instead of millions of people paying a modest monthly price for their medicine, the recent Pharma model has relied on a few hundred or a few thousand individuals paying huge amounts of money for an essential or life-saving medication.

This more or less works as long as people have good health insurance. If, however, the insurance has a high deductible or if someone is uninsured, access to a life-saving treatment could easily be out of reach.

Insurance companies are beginning to balk at the high cost of some new medicines. Drugs for hepatitis C can cost over $1,000 a pill. Even though such medicines are less toxic than older alternatives, some insurance plans require patients to “fail” less expensive treatments before they will cover the newer drugs.

Alzheimer’s Disease: Justifying High Drug Prices?

What if drug companies came up with truly effective medications for people with devastating conditions? If those conditions affected hundreds of thousands or millions of people, the health care system would likely collapse like a house of cards.

The holy grail for the pharmaceutical industry would be a treatment for Alzheimer’s disease. Note that we said treatment and not cure. If a drug company came up with an effective therapy against dementia, it could single-handedly bring down health care in America.

It is estimated that over 5 million people have Alzheimer’s disease in the U.S. A skilled memory care facility can charge anywhere from $60,000 to $90,000 a year.

A drug company could easily charge more than $100,000 to keep someone with Alzheimer’s disease from deteriorating. If the hypothetical drug helped patients improve, that would be a huge bonus. If that patient had to take the medicine daily for the rest of her life, it would be a bonanza for the company. Just try multiplying $100,000 times 5 million. You get a lot of zeroes, as in:


That is for one year.

Can Insurance Companies Survive?

We have no great love for insurance companies. That said, we cannot imagine that they can continue to pay extraordinarily high drug prices. Even the government can’t manage to cover the kind of high drug prices we anticipate in coming years.

The current situation is unsustainable. It isn’t clear, however, how it can be resolved. In the United States, drug companies can charge whatever the market will bear. The question is, what will the industry do if it breaks the health care system?

We welcome your thoughts in the comment section below.

Get The Graedons' Favorite Home Remedies Health Guide for FREE

Join our daily email newsletter with breaking health news, prescription drug information, home remedies AND you'll get a copy of our brand new full-length health guide — for FREE!

  1. g

    I have had A-fib since 2008, and I refuse to take the “modern” blood thinners as they run from $400 to $500 per month. During the 10-plus years that I have had A-fib I took coumadin for about four months. As a result of the coumadin I experienced a series of blood infections (never in my life time until coumadin), and stopped taking the coumaidin. I had a catheter ablation in August 2017 and have been A-fib free since.

    Prior to August 2017 the medical industry kept telling me that I will have a heart attack/stroke if I do not take the expensive blood thinners: Why haven’t I had a heart/attack stroke? Simple: Plant based diet, exercise, and hydration: Water is a natural blood thinner. The drug/medical industry does not want anyone to know that, as they cannot charge $400 – $500 per month for water. Corruption, greed, and avarice: That defines the pharmaceutical industry. Congress will do nothing.

  2. Penelope

    The Pharmaceutical industry is the most profitable sector of our economy, and by definition, their profits are on the back of sick people! (And often the poorest among us.) What is the matter with our country that we allow this brazen greed and violation of the anti-monopoly laws?

What Do You Think?

We invite you to share your thoughts with others, but remember that our comment section is a public forum. Please do not use your full first and last name if you want to keep details of your medical history anonymous. A first name and last initial or a pseudonym is acceptable. Advice from other commenters on this website is not a substitute for medical attention. Do not stop any medicine without checking with the prescriber. Stopping medication suddenly could result in serious harm. We expect comments to be civil in tone and language. By commenting, you agree to abide by our commenting policy and website terms & conditions. Comments that do not follow these policies will not be posted. Learn how your comment data is processed.

Your cart

Shipping and discount codes are added at checkout.